ArticlePloS one2015

The short-term cost-effectiveness of once-daily liraglutide versus once-weekly exenatide for the treatment of type 2 diabetes mellitus in the United States.

Bruce Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.